Chemours is Prepared to Support US Industry with Pivotal Next Generation, Low Global Warming Potential Technologies

The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Fluoroproducts and Chemical Solutions, applauds the 116th Congress in its recent passing of the bipartisan American Innovation and Manufacturing Act (AIM Act), which was signed into law by President Donald Trump as part of the year-end Omnibus package on December 27th.  Once enacted, the AIM Act is expected to deliver $38 billion in economic benefit to the US by 2027, create new jobs, and provide an orderly nation-wide phase down of hydrofluorocarbons (HFCs) in use today across multiple industries.